Immutep (IMMP) Change in Taxes (2014 - 2017)
Immutep's (IMMP) quarterly Change in Taxes came in at -$16187.8 in Q2 2017, down 3144.82% YoY from $531.65 in Q2 2016, and down 3144.82% on a QoQ basis from $531.65 in Q2 2016.
Immutep (IMMP) Change in Taxes (2014 - 2017) Analysis & Trends
Immutep (IMMP) has 4 years of Change in Taxes data on file, last reported at -$16187.8 in Q2 2017.
- Quarterly Change in Taxes fell 3144.82% year-over-year to -$16187.8 in Q2 2017, while the trailing twelve-month figure through Jun 2017 was -$22060.7 (changed N/A YoY) and the FY2017 annual result came in at -$16187.8, down 799.55% from the prior year.
- Change in Taxes declined to -$16187.8 in Q2 2017, from $531.65 in the prior quarter.
- In the past five years, Change in Taxes ranged from a high of $2992.3 in Q2 2015 to a low of -$16187.8 in Q2 2017.
- A 4-year average of -$5515.2 and a median of -$4432.6 in 2014 frame the typical range for Change in Taxes.
- Annual changes were most pronounced in 2015 — Change in Taxes jumped 131.84% — and 2017, when it slumped 3144.82%.
- Tracing IMMP's Change in Taxes over 4 years: stood at -$9396.8 in 2014, then soared by 131.84% to $2992.3 in 2015, then plunged by 82.23% to $531.65 in 2016, then plunged by 3144.82% to -$16187.8 in 2017.
- The last three Change in Taxes figures came in at -$16187.8 (Q2 2017), $531.65 (Q2 2016), and $2992.3 (Q2 2015), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 90.33 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Immutep | 56.46 Mn | -8.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | -16,187.83 |
| Jun 30, 2017 | -16,187.83 |
| Jun 30, 2016 | 531.65 |
| Jun 30, 2016 | 531.65 |
| Jun 30, 2015 | 2,992.30 |
| Jun 30, 2015 | 2,992.30 |
| Jun 30, 2014 | -9,396.78 |
| Jun 30, 2014 | -9,396.78 |